Background <p>Tumor-associated macrophages (TAMs) are critically involved in colorectal cancer (CRC) progression, yet their spatial and metabolic heterogeneity across primary and metastatic microenvironments remains poorly defined, limiting therapeutic development.</p> Methods <p>Integrated single-cell RNA sequencing was performed on 998,204 cells from a multicenter cohort encompassing primary CRC, adjacent normal tissue, liver and lymph node metastases, and peripheral blood. Computational analyses included…
Targeting SPP1+TAMs associated with liver metastasis reverses immunosuppression and synergizes with immunotherapy in colorectal cancer
Journal for ImmunoTherapy of Cancer | | Lin, Y., Chen, Z., Zhao, S., Zhao, L., Yang, C., Zhu, M., Ye, Y., Wang, S., Shen, Z.
Topics: colorectal-cancer, blood-cancer, cervical-cancer, immunotherapy, research
Read the full article at Journal for ImmunoTherapy of Cancer